A selective protein sensor for heparin detection

NMR Characterization of the Interactions Between Glycosaminoglycans and Proteins

Glycosaminoglycans (GAGs) constitute a considerable fraction of the glycoconjugates found on cellular membranes and in the extracellular matrix of virtually all mammalian tissues. The essential role of GAG-protein interactions in the regulation of physiological processes has been recognized for decades. However, the underlying molecular basis of these interactions has only emerged since 1990s. The binding specificity of GAGs is encoded in their primary structures, but ultimately depends on how their functional groups are presented to a protein in the three-dimensional space. This review focuses on the application of NMR spectroscopy on the characterization of the GAG-protein interactions. Examples of interpretation of the complex mechanism and characterization of structural motifs involved in the GAG-protein interactions are given. Selected families of GAG-binding proteins investigated using NMR are also described.

Collective sampling of intact anionic polysaccharide components and application in quantitative determination by LC-MS

Anionic polysaccharides, such as glycosaminoglycans (GAGs) and alginate, readily undergo source-induced fragmentation when analyzed by electrospray mass spectrometry with the use of high source cone voltage. The dissociation chemistry converts all components of a polysaccharide into a small set of structurally characteristic small saccharides. This chemistry enables the collective detection of a polysaccharide through the detection of one or more small saccharides. This ability, combined with the elution of polysaccharides as relatively compact bands using ion-pairing reverse phase liquid chromatography, created a unique opportunity for the development of LC-MS methods suitable for the quantitative analysis of intact anionic polysaccharides. Feasibility of this approach is demonstrated with a mixture of heparin, chondroitin sulfate A, and alginate.

Analysis and characterization of heparin impurities

This review discusses recent developments in analytical methods available for the sensitive separation, detection and structural characterization of heparin contaminants. The adulteration of raw heparin with oversulfated chondroitin sulfate (OSCS) in 2007–2008 spawned a global crisis resulting in extensive revisions to the pharmacopeia monographs on heparin and prompting the FDA to recommend the development of additional physicochemical methods for the analysis of heparin purity. The analytical chemistry community quickly responded to this challenge, developing a wide variety of innovative approaches, several of which are reported in this special issue. This review provides an overview of methods of heparin isolation and digestion, discusses known heparin contaminants, including OSCS, and summarizes recent publications on heparin impurity analysis using sensors, near-IR, Raman, and NMR spectroscopy, as well as electrophoretic and chromatographic separations.

Figure

Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products

Heparin is a commonly implemented anticoagulant used to treat critically ill patients. Recently, a number of commercial lots of heparin products were found to be contaminated with an oversulfated chondroitin sulfate (OSCS) derivative that could elicit a hypotensive response in pigs following a single high-dose infusion. Using both contaminated heparin products and the synthetically produced derivative, we showed that the OSCS produces dose-dependent hypotension in pigs. The no observed effect level (NOEL) for this contaminant appears to be approximately 1mg/kg, corresponding to a contamination level of approximately 3%. We also demonstrated that OSCS can be identified in heparin products using a simple, inexpensive, commercially available heparin enzyme immunoassay (EIA) kit that has a limit of detection of approximately 0.1%, well below the NOEL. This kit may provide a useful method to test heparin products for contamination with oversulfated GAG derivatives.

Label-free detection of heparin, streptavidin, and other probes by pulsed streaming potentials in plastic microfluidic channels

In this paper, pulsed streaming potentials generated in plastic microfluidic channels are used for the label-free detection of some model analytes. The microchannels are fabricated with the commodity plastic cyclic olefin copolymer (COC), and the detection signal arises from a change in the surface charge upon analyte adsorption on the modified microchannel surface. The role of the surface modification is to confer the microchannel with a predetermined charge and a particular specificity toward the adsorption of the target analyte. In this work, several target probes displaying different levels of specificity were investigated. Heparin and streptavidin were detected by adsorption on microchannel surfaces modified with protamine and biotin, respectively, whereas bovine serum albumin (BSA) and methylene blue (MB) showed nonspecific adsorption on almost any modified or unmodified COC microchannel surface. The magnitude of the streaming potential was found to be proportional to the liquid pressure and the surface charge of the microchannel in accord with the Smoluchowski equation. Because the relative polarity of the streaming potential is determined by the surface charge, the most straightforward detection with this method occurs when the charge is reversed upon analyte adsorption. This strategy was used for the species described in this work, and the lowest concentrations detected were approximately 0.01 units/mL for heparin (below clinical relevance), approximately 10 (-9) M for BSA, and approximately 10 (-6) M for MB. Unlike the conventional method of steady flow, in this work, the streaming potentials were measured under pulsed conditions of flow and using nonreference electrodes. This approach removes the need of special electrolytes as it is usually required when using reference electrodes, and at the same time, it mitigates the interference of electrochemical drift from the electrodes. Relative standard deviations of approximately 1-2% and measuring times of approximately 10 s are readily attained with this experimental setup. The on-channel modification of the surface was carried out by UV-photografting methods given the significant UV transparency of COC.

An EQCM study on the interaction of heparin with the charge-transfer complex generated during o-tolidine electrooxidation: A biosensing mode with a dynamically renewed surface

The electrooxidation of o-tolidine (oTD) was investigated via the electrochemical quartz crystal microbalance (EQCM) technique. The formation and breakage of the poorly soluble charge-transfer complex (CTC) occurred during the redox switching of oTD, and the CTC precipitation on and its removal from the electrode surface led to a V-shaped frequency response to the cyclic voltammetric switching of oTD. The V-shaped frequency response to the redox switching of the CTC/oTD "couple" and the electrode-collection efficiency of the CTC precipitate were notably enhanced by the introduction of sodium heparin due to the formation of the CTC-heparin adduct as reported here for the first time. FTIR and UV-Vis characterizations also supported the interaction between the CTC and heparin. The molar ratio of the positively charged CTC to negatively charged heparin of the adduct was estimated here to be between 31.5 and 36.5, being close to the anticipated value, 37.5, for the full electrical neutralization in the adduct. An EQCM-based biosensor featured by a dynamically renewed surface of the detection electrode was proposed for heparin assay, with a limit of detection of 18.5 nM (S/N=3) in pH 6.0 Britton-Robinson buffer solution containing a 10-fold diluted blood serum. This method is convenient in operation and highly free from the interference from coexisting substances including proteins. The new and intriguing biosensing concept based on the labile CTC-"target" adduct is featured by a dynamically renewable and regenerable surface of the detection electrode, and it is highly recommended for wide biosensing and electroanalytical applications.

Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM)

Using the hyaluronic acid (HA) binding region of the receptor for hyaluronan-mediated motility (RHAMM) as a model, a molecular perspective for peptide mimicry of the natural ligand was established by comparing the interaction sites of HA and unnatural peptide-ligands to RHAMM. This was accomplished by obtaining a series of octapeptide-ligands through screening experiments that bound to the HA binding domains of RHAMM (amino acids 517-576) and could be displaced by HA. These molecules were computationally docked onto a three-dimensional NMR based model of RHAMM. The NMR model showed that RHAMM(517-576) was a set of three helices, two of which contained the HA binding domains (HABDs) flanking a central groove. The structure was stabilized by hydrophobic interactions from four pairs of Val and Ile side chains extending into the groove. The presence of solvent exposed, positively charged side chains spaced 11 A apart matched the spacing of negative charges on HA. Docking experiments using flexible natural and artificial ligands demonstrated that HA and peptide-mimetics preferentially bound to the second helix that contains HABD-2. Three salt bridges between HA carboxylates and Lys548, Lys553 and Lys560 and two hydrophobic interactions involving Val538 and Val559 were predicted to stabilize the RHAMM-HA complex. The high affinity peptides and HA utilized the same charged residues, with additional contacts to other basic residues. However, hydrophobic contacts do not contribute to affinity for peptide ligand-RHAMM complexes. These results offer insight into how selectivity is achieved in the binding of HA to RHAMM, and how peptide competitors may compete for binding with HA on a single hyaladherin.

Discovery of selective aldo-keto reductase ligands—an on-bead assay strategy

An enzyme labeling and screening strategy for the discovery of ligands selective in binding two structurally similar members of the aldo-keto reductase family of enzymes is reported. The resulting fluorescence microscope data obtained by screening a 74,088 member library led to the identification of selective ligands for aldose reductase (ALR2) and aldehyde reductase (ALR1). Resynthesis results validate the selectivity of these ligands.

Spacrcan binding to hyaluronan and other glycosaminoglycans. Molecular and biochemical studies

Photoreceptors project from the outer retinal surface into a specialized glycocalyx, the interphotoreceptor matrix (IPM), which contains hyaluronan (HA) and two novel proteoglycans, Spacr and Spacrcan. This matrix must be stable enough to function in the attachment of the retina to the outer eye wall yet porous enough to allow movement of metabolites between these tissues. How this matrix is organized is not known. HA is a potential candidate in IPM organization since biochemical studies show that these proteoglycans bind HA. RHAMM (receptor for HA-mediated motility)-type HA binding motifs (HABMs) are present in their deduced amino acid sequence and may be the sites of this HA interaction. To test this hypothesis, we subcloned three fragments of mouse Spacrcan that contain the putative HABMs. We found that each recombinant fragment binds HA. Binding decreased when residues in the HABMs were mutated. This provides direct evidence that the RHAMM-type HABMs in Spacrcan are involved in hyaluronan binding. Since chondroitin sulfate and heparan sulfate proteoglycans are important for retinal development and function, we also evaluated the binding of these recombinant proteins to heparin and chondroitin sulfates, the glycosaminoglycan side chain of these proteoglycans. We found that each recombinant protein bound to both heparin and chondroitin sulfates. Binding to chondroitin sulfates involved these HABMs, because mutagenesis reduced binding. Binding to heparin was probably not mediated through these HABMs since heparin binding persisted following their mutagenesis. These studies provide the first evidence defining the sites of protein-carbohydrate interaction of molecules present in the IPM.